Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanno, Y.
Right arrow Articles by Tsuji, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanno, Y.
Right arrow Articles by Tsuji, S.
NEUROLOGY 1993;43:1198
© 1993 American Academy of Neurology

Uniform tissue distribution of tRNALys mutation in mitochondrial DNA in MERRF patients

Y. Tanno, MD, M. Yoneda, MD, K. Tanaka, MD, R. Kondo, MD, I. Hozumi, MD, K. Wakabayashi, MD, M. Yamada, MD, N. Fukuhara, MD, F. Ikuta, MD and S. Tsuji, MD

Department of Internal Medicine (Dr. Tanno), National Sanatorium Nishi-Ojiya Hospital, Ojiya; the Departments of Neurology (Drs. Tanno, Yoneda, Tanaka, Kondo, Hozumi. and Tsuji) and Pathology (Drs. Wakabayashi, Yamada, and Ikuta), Brain Research Institute, Niigata University, Niigata; and the Department of Neurology (Dr. Fukuhara), National Saigata Hospital, Oogata-machi, Japan.

We documented the presence of a point mutation in the tRNALys gene of mitochondrial DNA (mtDNA) in various postmortem tissues from two patients with myoclonus epilepsy associated with ragged-red fibers (MERRF). The percentages of the mutant mtDNA were similar (93 to 99%) in both clinically affected and unaffected tissues, suggesting that preferential clinical involvement of certain tissues in MERRF is based not only on the variation of distribution of the mutant mtDNA, but also on other factors such as differences in the threshold in various CNS regions and organs.

Address correspondence and reprint requests to Dr. Y. Tanno, Department of Neurology, Brain Research Institute, Niigata University, 1 Asahimachi, Niigata 951, Japan.

Supported in part by a Grant-in-Aid for Scientific Research on Priority Area, Ministry of Education, Science and Culture, and Grant (2A-2) from the National Center of Neurology and Psychiatry (NCNP) of the Ministry of Health and Welfare, Japan.

Received June 19, 1992. Accepted for publication in final form October 1,1992.




This article has been cited by other articles:


Home page
NeurologyHome page
T. Klopstock, M. Jaksch, and T. Gasser
Age and cause of death in mitochondrial diseases
Neurology, September 1, 1999; 53(4): 855 - 855.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Zhou, A. Chomyn, G. Attardi, and C. A. Miller
Myoclonic Epilepsy and Ragged Red Fibers (MERRF) Syndrome: Selective Vulnerability of CNS Neurons Does Not Correlate with the Level of Mitochondrial tRNAlys Mutation in Individual Neuronal Isolates
J. Neurosci., October 15, 1997; 17(20): 7746 - 7753.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by AAN Enterprises, Inc.